Sanofi Makes Good On Outsourcing Promise In Deal With Covance
Sanofi-Aventis, which last year announced plans to transform its R&D model by tapping external sources, announced a multi-layered 10-year partnership with the contract research organization Covance Sept. 30.
You may also be interested in...
As Big Pharma continues its restructuring initiatives to outsource services to lower-cost emerging markets, Chinese and U.S. contract research organizations with the largest footprints and broadest capabilities will benefit from the ongoing trend, according to two recently released surveys on the CRO industry
Noting its recent five-year contract with Pfizer, the CRO predicts 13% revenue growth for fiscal 2012.
Contract research organizations Icon and Parexel will become Pfizer's primary clinical trail service providers under the new partnerships.